Sync-Rx Overview

  • Founded
  • 2007
  • Status
  • Acquired/​Merged
  • Employees
  • 11
  • Latest Deal Type
  • M&A
  • Latest Deal Amount
  • $17.1M
Latest Deal Amount

Sync-Rx General Information


Developer of cardiovascular catheterization technologies. The company develops software that optimizes and facilitates transcatheter cardiovascular interventions using automated online image processing.

Contact Information

Ownership Status
Financing Status
Formerly VC-backed
Primary Industry
Other Healthcare Technology Systems
Other Industries
Application Software
Primary Office
  • 8 HaMelacha Street
  • POB 8072
  • Netanya 42505
  • Israel
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Sync-Rx Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Merger/Acquisition 24-Nov-2012 $17.1M 000.00 Completed Startup
1. Buyout/LBO Completed Startup
To view Sync-Rx’s complete valuation and funding history, request access »

Sync-Rx Signals

Growth Rate

0.80% Weekly
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers


Similarweb Unique Visitors


Majestic Referring Domains


PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Sync-Rx Former Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
Rafael Development Corporation Corporate Venture Capital Majority 000 0000 000000 0
To view Sync-Rx’s complete investors history, request access »